• Between 2012 and 2024 AMEND provided £191,000 in research funding to 20 researchers, covering all of the diseases we support.  This was deemed to be feasible only when AMEND has sufficient surplus funds.  Unfortunately, in order to secure financial security for the future of the charity, the Trustee Board suspended the AMEND Research Award Programme in 2024.

    Nevertheless, AMEND remains involved in providing the patient voice to researchers in the UK and Europe.  Please contact the CEO for more information on how they and our communities can help or check out our Community Advisory Group project on this website.

    You can read about all the research projects we funded from 2012-2024 below.

     

    Specific Grants

    The Elliot Dallen Award for ACC Research formed part of the annual grants programme for 2022-2024.  The Elliot Dallen Trust was set up by the family and friends of the late Elliot Dallen, who had ACC. The Elliot Dallen Trust granted AMEND a fund of £10,000 per year for three years specifically for research into adrenocortical cancer.  We thank them for trusting us with this important responsibility.

    .